Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment
Haiying Que, Weiqi Hong, Tianxia Lan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

COVID-19 Therapeutic Potential of Natural Products
Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9589-9589
Open Access | Times Cited: 19
The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2
Yuan Hu, Lili Liu, Shenghua Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 5, pp. 5175-5192
Open Access | Times Cited: 6
Effects of N-succinyl-chitosan coating on properties of astaxanthin-loaded PEG-liposomes: Environmental stability, antioxidant/antibacterial activities, and in vitro release
Aiyang Liu, Xiuhang Chai, Shuang Zhu, et al.
International Journal of Biological Macromolecules (2023) Vol. 244, pp. 125311-125311
Closed Access | Times Cited: 16
Nanostructures in Chinese herbal medicines (CHMs) for potential therapy
Yali Zhang, Yalei Wang, Ke Yan, et al.
Nanoscale Horizons (2023) Vol. 8, Iss. 8, pp. 976-990
Closed Access | Times Cited: 15
Zeolitic Imidazolate Framework-8 (ZIF-8) as a Drug Delivery Vehicle for the Transport and Release of Telomerase Inhibitor BIBR 1532
Shunyu Zhang, Jinxia Li, Liang Yan, et al.
Nanomaterials (2023) Vol. 13, Iss. 11, pp. 1779-1779
Open Access | Times Cited: 15
New insights into the roles of olfactory receptors in cardiovascular disease
Kangru Shi, Yang Jiao, Ling Yang, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 7, pp. 1615-1626
Closed Access | Times Cited: 4
Liposomal drug delivery to the lungs: a post covid-19 scenario
Sivadas Swathi Krishna, M. S. Sudheesh, Vidya Viswanad
Journal of Liposome Research (2023) Vol. 33, Iss. 4, pp. 410-424
Closed Access | Times Cited: 9
Effect and safety of mesenchymal stem cells for patients with COVID‐19: Systematic review and meta‐analysis with trial sequential analysis
Zhijing Zhang, Shuai Shao, Xuefeng Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 7
Prevention of Hypercholesterolemia with “Liposomes in Microspheres” Composite Carriers: A Promising Approach for Intestinal-Targeted Oral Delivery of Astaxanthin
Aiyang Liu, Mengxue He, Chunhuan Liu, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 12, pp. 6118-6132
Closed Access | Times Cited: 2
“Three medicines and three formulas” in COVID-19: from bench to bedside
Guangxu Xiao, Simeng Wang, Ruijiao Wang, et al.
Acupuncture and Herbal Medicine (2023) Vol. 3, Iss. 4, pp. 309-322
Open Access | Times Cited: 5
Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak
Bedanta Bhattacharjee, Abu Md Ashif Ikbal, Atika Farooqui, et al.
Chemical Papers (2023) Vol. 77, Iss. 8, pp. 4107-4130
Open Access | Times Cited: 4
Nanomaterials as a Versatile Tool for COVID-19 Treatment
Safieh Zeinali, Zeinab Moafian, Rabia Arshad, et al.
BioNanoScience (2024) Vol. 14, Iss. 4, pp. 3950-3987
Closed Access | Times Cited: 1
Applications of plant‐derived extracellular vesicles in medicine
Yawen Zhu, Junqi Zhao, Haoran Ding, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 1
World’s top 50 high-impact research studies in traditional medicine in 2024
Bo Pang, Yibing Chen, Shuo Wang, et al.
Acupuncture and Herbal Medicine (2024) Vol. 4, Iss. 4, pp. 552-558
Open Access | Times Cited: 1
Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
Junlan Tan, Jian Yi, Xianya Cao, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 1963-1978
Open Access | Times Cited: 3
Celastrol nano-emulsions selectively regulate apoptosis of synovial macrophage for alleviating rheumatoid arthritis
Chenglong Li, Yan Li, Qing Zeng, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 6, pp. 724-735
Closed Access
Towards natural polymers and nanoparticles as nanotherapies to combat COVID-19
Clarity Ropafadzo Mapengo
Elsevier eBooks (2024), pp. 297-315
Closed Access
A Novel Triptolide Nano-Liposome with Mitochondrial Targeting for Treatment of Hepatocellular Carcinoma
Lili Zhou, Yang Du, Yuancui Shang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 12975-12998
Open Access
Applications of Nanomedicine in Brain Tumor Therapy: Nanocarrierbased Drug Delivery Platforms, CChallenges, and Perspectives
Ravinder Verma, Lakshita Rao, Harish Kumar, et al.
Recent Patents on Nanotechnology (2023) Vol. 19, Iss. 1, pp. 99-119
Closed Access | Times Cited: 1
Page 1

Scroll to top